Johnson & Johnson offers $8.9 billion to settle talc 'cancer' claims
This is an increase of $6.9 billion over the $2 billion previously committed by Johnson & Johnson.
This is an increase of $6.9 billion over the $2 billion previously committed by Johnson & Johnson.
The quartet of vaccine-makers from the western world are ascertaining the need to tweak their vaccines for the Omicron, whereas WHO states it is too early to comment on its virulence.
Government sets up experts’ panel to determine compensation amount.